Literature DB >> 31488412

Race/Ethnicity and Accuracy of Self-Reported Female First-Degree Family History of Breast and Other Cancers in the Northern California Breast Cancer Family Registry.

Esther M John1,2,3,4, Alison J Canchola5,6, Meera Sangaramoorthy5,6, Jocelyn Koo5,4, Alice S Whittemore3,7, Dee W West5,3.   

Abstract

BACKGROUND: Few studies have evaluated accuracy of self-reported family history of breast and other cancers in racial/ethnic minorities.
METHODS: We assessed the accuracy of cancer family history reports by women with breast cancer (probands) from the Northern California Breast Cancer Family Registry compared with 2 reference standards: personal cancer history reports by female first-degree relatives and California Cancer Registry records.
RESULTS: Probands reported breast cancer in first-degree relatives with high accuracy, but accuracy was lower for other cancers. Sensitivity (percentage correctly identifying relatives with cancer) was 93% [95% confidence interval (CI), 89.5-95.4] when compared with the relatives' self-report of breast cancer as the reference standard and varied little by proband race/ethnicity and other demographic factors, except for marginally lower sensitivity for Hispanic white probands (87.3%; 95% CI, 78.0-93.1; P = 0.07) than non-Hispanic white probands (95.1%; 95% CI, 88.9-98.0). Accuracy was also high when compared with cancer registry records as the reference standard, with a sensitivity of 95.5% (95% CI, 93.4-96.9) for breast cancer, but lower sensitivity for Hispanic white probands (91.2%; 95% CI, 84.4-95.2; P = 0.05) and probands with low English language proficiency (80%; 95% CI, 52.8-93.5; P < 0.01).
CONCLUSIONS: Non-Hispanic white, African American, and Asian American probands reported first-degree breast cancer family history with high accuracy, although sensitivity was lower for Hispanic white probands and those with low English language proficiency. IMPACT: Self-reported family history of breast cancer in first-degree relatives is highly accurate and can be used as a reliable standard when other validation methods are not available. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2019        PMID: 31488412      PMCID: PMC6825587          DOI: 10.1158/1055-9965.EPI-19-0444

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  40 in total

1.  A GEE approach to estimating sensitivity and specificity and coverage properties of the confidence intervals.

Authors:  M R Sternberg; A Hadgu
Journal:  Stat Med       Date:  2001 May 15-30       Impact factor: 2.373

2.  Reliability of self-reported family history of cancer in a large case-control study of lymphoma.

Authors:  Ellen T Chang; Karin Ekström Smedby; Henrik Hjalgrim; Bengt Glimelius; Hans-Olov Adami
Journal:  J Natl Cancer Inst       Date:  2006-01-04       Impact factor: 13.506

3.  Perceived Susceptibility to Cervical Cancer among African American Women in the Mississippi Delta: Does Adherence to Screening Matter?

Authors:  Elena G Gibson; Julia C Gage; Philip E Castle; Isabel C Scarinci
Journal:  Womens Health Issues       Date:  2018-11-03

4.  Family history and risk of breast cancer in hispanic and non-hispanic women: the New Mexico Women's Health Study.

Authors:  R Li; F D Gilliland; K B Baumgartner; J Samet
Journal:  Cancer Causes Control       Date:  2001-10       Impact factor: 2.506

5.  Enrollment and biospecimen collection in a multiethnic family cohort: the Northern California site of the Breast Cancer Family Registry.

Authors:  Esther M John; Meera Sangaramoorthy; Jocelyn Koo; Alice S Whittemore; Dee W West
Journal:  Cancer Causes Control       Date:  2019-03-05       Impact factor: 2.506

6.  Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries.

Authors:  M M Bergmann; E E Calle; C A Mervis; H L Miracle-McMahill; M J Thun; C W Heath
Journal:  Am J Epidemiol       Date:  1998-03-15       Impact factor: 4.897

7.  Racial differences in the familial aggregation of breast cancer and other female cancers.

Authors:  Michael S Simon; Jeannette F Korczak; Cecilia L Yee; Janet R Daling; Kathleen E Malone; Leslie Bernstein; Polly A Marchbanks; Suzanne G Folger; Jill A McDonald; Sandra A Norman; Brian L Strom; Dennis Deapen; Giske Ursin; Ronald T Burkman; Michael F Press; Ann G Schwartz; Robert Spirtas
Journal:  Breast Cancer Res Treat       Date:  2005-02       Impact factor: 4.872

8.  Accuracy of family cancer history in breast cancer patients.

Authors:  B Theis; N Boyd; G Lockwood; D Tritchler
Journal:  Eur J Cancer Prev       Date:  1994-07       Impact factor: 2.497

9.  Accuracy of reports of familial breast cancer in a case-control series.

Authors:  M E Parent; P Ghadirian; A Lacroix; C Perret
Journal:  Epidemiology       Date:  1995-03       Impact factor: 4.822

10.  The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.

Authors:  Esther M John; John L Hopper; Jeanne C Beck; Julia A Knight; Susan L Neuhausen; Ruby T Senie; Argyrios Ziogas; Irene L Andrulis; Hoda Anton-Culver; Norman Boyd; Saundra S Buys; Mary B Daly; Frances P O'Malley; Regina M Santella; Melissa C Southey; Vickie L Venne; Deon J Venter; Dee W West; Alice S Whittemore; Daniela Seminara
Journal:  Breast Cancer Res       Date:  2004-05-19       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.